Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 2
1993 2
1994 3
1995 5
1996 3
1997 3
1998 3
1999 2
2000 4
2001 3
2002 2
2003 5
2004 7
2005 6
2006 7
2007 8
2008 9
2009 9
2010 5
2011 10
2012 5
2013 5
2014 8
2015 6
2016 8
2017 10
2018 4
2019 8
2020 3
2021 1
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Comment le programme d’investissements d’avenir a-t-il stimulé la recherche et l’innovation en santé ?
Bordet R, Dantonel JC, Vacaresse E, Le Jeunne C, Benhabiles N, Beretz A, Boitard C, Debette S, Duluc G, Froguel P, Garbil B, Lyonnet S, Mahfoudi A, Marquet P, Mouthon F, Rascol O, Richard V, Simon E, Varoqueaux N, Watier H, Zins M. Bordet R, et al. Among authors: watier h. Therapie. 2022 Jan-Feb;77(1):11-17. doi: 10.1016/j.therap.2022.01.005. Epub 2022 Jan 12. Therapie. 2022. PMID: 35101283 French. No abstract available.
Why is there no biosimilar of Erbitux®?
Douez E, D'Atri V, Guillarme D, Antier D, Guerriaud M, Beck A, Watier H, Foucault-Fruchard L. Douez E, et al. Among authors: watier h. J Pharm Biomed Anal. 2023 Sep 20;234:115544. doi: 10.1016/j.jpba.2023.115544. Epub 2023 Jun 22. J Pharm Biomed Anal. 2023. PMID: 37418870 Free article. Review.
Theranostic of biopharmaceuticals.
Chaigne B, Watier H. Chaigne B, et al. Among authors: watier h. Pharmacol Ther. 2017 Jul;175:67-74. doi: 10.1016/j.pharmthera.2017.02.035. Epub 2017 Feb 14. Pharmacol Ther. 2017. PMID: 28223229 Review.
Obinutuzumab: what is there to learn from clinical trials?
Cartron G, Watier H. Cartron G, et al. Among authors: watier h. Blood. 2017 Aug 3;130(5):581-589. doi: 10.1182/blood-2017-03-771832. Epub 2017 Jun 5. Blood. 2017. PMID: 28584136 Free article. Review.
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies.
Antunes A, Alvarez-Vallina L, Bertoglio F, Bouquin N, Cornen S, Duffieux F, Ferré P, Gillet R, Jorgensen C, Leick MB, Maillère B, Negre H, Pelegrin M, Poirier N, Reusch D, Robert B, Serre G, Vicari A, Villalba M, Volpers C, Vuddamalay G, Watier H, Wurch T, Zabeau L, Zielonka S, Zhang B, Beck A, Martineau P. Antunes A, et al. Among authors: watier h. MAbs. 2023 Jan-Dec;15(1):2211692. doi: 10.1080/19420862.2023.2211692. MAbs. 2023. PMID: 37184206 Free PMC article.
[A word from the coordinators].
Pèlegrin A, Beck A, Watier H. Pèlegrin A, et al. Among authors: watier h. Med Sci (Paris). 2019 Dec;35(12):923. doi: 10.1051/medsci/2019245. Epub 2020 Jan 6. Med Sci (Paris). 2019. PMID: 31903894 Free article. French. No abstract available.
[Monoclonal antibodies for monogenic diseases: a 2019 update].
Bauvois A, Larivière M, Watier H, Maillot F. Bauvois A, et al. Among authors: watier h. Med Sci (Paris). 2019 Dec;35(12):1026-1028. doi: 10.1051/medsci/2019203. Epub 2020 Jan 6. Med Sci (Paris). 2019. PMID: 31903913 Free article. Review. French.
159 results